<DOC>
	<DOCNO>NCT01911845</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy ABT-450/ritonavir/ABT-267 ( ABT-450/r/ABT-267 ; ABT-450 also know paritaprevir ; ABT-267 also know ombitasvir ) ABT-333 ( also know dasabuvir ) coadministered ribavirin ( RBV ) hepatitis C virus ( HCV ) genotype 1-infected adult take methadone buprenorphine ± naloxone .</brief_summary>
	<brief_title>An Open-label , Single Arm , Phase 2 Study Evaluate ABT-450/r/ABT-267 ABT-333 With Ribavirin ( RBV ) Adults With Genotype 1 HCV Infection Taking Methadone Buprenorphine</brief_title>
	<detailed_description>This study consist 2 period : 12-week treatment period 48-week post-treatment period ( participant receive study drug ) . All participant receive least 1 dose study drug follow 48 week post-treatment monitor safety , HCV RNA , emergence and/or persistence resistant viral variant , assessment patient-reported outcome ( PRO ) instrument .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Females must practice specific form birth control study treatment , postmenopausal 2 year surgically sterile . Chronic HCV infection prior study enrollment . Screening laboratory result indicate HCV genotype 1infection . Subject must treatment naive previous pegylated interferon/ribavirin treatment experience . Subjects must stable opioid replacement therapy methadone buprenorphine ± naloxone least 6 month prior screen . Positive test result Hepatitis B surface antigen ( HBsAg ) antiHuman Immunodeficiency virus antibody ( HIV Ab ) screening . Prior therapy direct act antiviral agent treatment HCV , include telaprevir boceprevir . Females pregnant plan become pregnant , breastfeeding , male whose partner pregnant plan become pregnant within 7 month ( per local RBV label ) last dose study drug . Any current past clinical evidence cirrhosis ascites esophageal varix , prior biopsy show cirrhosis , e.g. , Metavir Score &gt; 3 Ishak score &gt; 4 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>HCV Genotype 1</keyword>
	<keyword>Hepatitis Genotype 1</keyword>
	<keyword>Interferon Free</keyword>
	<keyword>methadone</keyword>
	<keyword>HCV</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Viekira Pak</keyword>
	<keyword>paritaprevir</keyword>
	<keyword>Viekira</keyword>
	<keyword>ombitasvir</keyword>
	<keyword>dasabuvir</keyword>
</DOC>